<DOC>
	<DOCNO>NCT00395694</DOCNO>
	<brief_summary>To evaluate safety information BW430C administer use low start dos slow dose escalation recommend Global Data Sheet</brief_summary>
	<brief_title>Clinical Evaluation BW430C Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>Inclusion criterion : Epilepsy partial seizure Tonic clonic seizure Generalized seizure LennoxGastaut Subjects whose seizure easily recognizable least one seizure per month count 8 consecutive week prior start study drug . Concurrent AEDs : Subjects take concurrent VPA . Exclusion criterion : Previous participation study Lamictal Known hypersensitivity drug Pregnant woman nurse mother woman may pregnant woman contemplate pregnancy study period</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>Incidence rash</keyword>
	<keyword>safety evaluation initial dose</keyword>
	<keyword>patient Valproic acid</keyword>
</DOC>